India’s Natco Mulls HIV/AIDS Antiviral, Other Drugs For Next CL Attempt
This article was originally published in PharmAsia News
Executive Summary
Natco Pharma, fresh from getting India’s first compulsory license to produce a generic of a patent-covered branded drug, is looking for other treatments considered life-saving for additional CLs.